Amanote Research
Register
Sign In
Natural Killer P30 Receptor (NKp30; NCR3; CD337)
Science-Business eXchange
doi 10.1038/scibx.2013.883
Full Text
Open PDF
Abstract
Available in
full text
Date
August 1, 2013
Authors
Unknown
Publisher
Springer Science and Business Media LLC
Related search
Natural Cytotoxicity Triggering Receptor 1 (NCR1; NKP46; CD335); Natural Killer P30 Receptor (NKp30; NCR3; CD337)
Science-Business eXchange
Deficient Natural Killer Cell NKp30-mediated Function and Altered NCR3 Splice Variants in Hepatocellular Carcinoma
Hepatology
Medicine
Hepatology
NCR3/NKp30 Contributes to Pathogenesis in Primary Sjogren's Syndrome
Science Translational Medicine
Medicine
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies
Frontiers in Immunology
Allergy
Immunology
Enhancing Natural Killer Cell-Mediated Lysis of Lymphoma Cells by Combining Therapeutic Antibodies With CD20-Specific Immunoligands Engaging NKG2D or NKp30
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Increased Natural Killer Cell Cytotoxicity and NKp30 Expression Protects Against Hepatitis C Virus Infection in High-Risk Individuals and Inhibits Replication in Vitro
Hepatology
Medicine
Hepatology
Natural-Killer-Lymphozyt
Cobalt-Mediated Dimerization of the Human Natural Killer Cell Inhibitory Receptor
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Frontiers in Immunology
Allergy
Immunology
